Mifepristone/Norethidranum Dipropionas

米非司酮/双炔失碳酯

Report date: 2025/11/17 14:45:35

Base Information

Drug NameMifepristone/Norethidranum Dipropionas
Drug Alias Name复方米非司酮片紫韵
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor antagonistsVoltage-gated calcium channel blockersGlucocorticoid receptor antagonists
TargetsProgesterone receptorVoltage-gated calcium channelGlucocorticoid receptor
Therapy Area/IndicationsContraception
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes MifepristoneNorethidranum Dipropionas
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsContraception
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A